Skip to main content
Caplight Logo









Respinor AS

Respinor AS

Private
OsloHealthcare & Life Scienceshttps://respinor.com/

Last Round

Convertible Debt

Jul 21, 2022

Total Funding Raised

$6.99M

Company Overview

Respinor AS is a medical technology company that develops non-invasive, ultrasound-based devices for continuous diaphragm monitoring in critically ill patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

diaphragm monitoringultrasound medical devicemechanical ventilationintensive careICU monitoringpoint of care ultrasoundPOCUSrespiratory monitoringnon-invasive monitoringweaning from ventilationclinical decision supportmedical imagingmedtechsignal processinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Respinor AS Comparables

Compare Respinor AS with similar companies based on industry and business-model similarity.

Respinor AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stimdia Medical
74%
Liberate Medical
72%
Lungpacer Medical
70%

Respinor AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJul 21, 2022
Private PlacementJan 4, 2022
GrantDec 11, 2020
GrantApr 20, 2018
GrantDec 1, 2016
Seed
Sep 1, 2016

Key People

Founding team and executive leadership

Trude Tingvoll

Chief Executive Officer

Executive Team

Respinor AS Investors

Notable investors and investment history

Respinor AS investors
InvestorRounds
Inven2Seed
The Research Council of NorwayGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 4, 2026

    Monthly visitors increased 111% MoM, reaching 1.7K.

  • Mar 27, 2025

    Monthly visitors increased 78% MoM.

Respinor AS Filings

Explore SEC and related filing metadata, where available.

Respinor AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Respinor AS's valuation, stock price, and market status.

Is Respinor AS a public or private company?

Respinor AS is a private company.

What is the current stock price of Respinor AS?

Respinor AS is a private company with no public stock price. No recent secondary market data is available.

How much is Respinor AS worth (valuation)?

Valuation information for Respinor AS is not publicly available.

Can I buy Respinor AS stock?

Respinor AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Respinor AS's last funding round?

Respinor AS's most recent funding round was Convertible Debt on July 21, 2022.

Who are the main investors in Respinor AS?

Key investors in Respinor AS include Inven2.

Will Respinor AS IPO soon?

No public IPO plans have been announced for Respinor AS.

How can I track Respinor AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Respinor AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range13
Year Founded2015
Last FundingJul 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?